274 related articles for article (PubMed ID: 19833663)
1. Scoring system for renal pathology in Fabry disease: report of the International Study Group of Fabry Nephropathy (ISGFN).
Fogo AB; Bostad L; Svarstad E; Cook WJ; Moll S; Barbey F; Geldenhuys L; West M; Ferluga D; Vujkovac B; Howie AJ; Burns A; Reeve R; Waldek S; Noël LH; Grünfeld JP; Valbuena C; Oliveira JP; Müller J; Breunig F; Zhang X; Warnock DG;
Nephrol Dial Transplant; 2010 Jul; 25(7):2168-77. PubMed ID: 19833663
[TBL] [Abstract][Full Text] [Related]
2. Kidney biopsy findings in heterozygous Fabry disease females with early nephropathy.
Valbuena C; Carvalho E; Bustorff M; Ganhão M; Relvas S; Nogueira R; Carneiro F; Oliveira JP
Virchows Arch; 2008 Oct; 453(4):329-38. PubMed ID: 18769939
[TBL] [Abstract][Full Text] [Related]
3. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
4. Mosaicism of podocyte involvement is related to podocyte injury in females with Fabry disease.
Mauer M; Glynn E; Svarstad E; Tøndel C; Gubler MC; West M; Sokolovskiy A; Whitley C; Najafian B
PLoS One; 2014; 9(11):e112188. PubMed ID: 25386848
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Dose-Dependent Agalsidase Effects on Kidney Histology in Fabry Disease.
Skrunes R; Tøndel C; Leh S; Larsen KK; Houge G; Davidsen ES; Hollak C; van Kuilenburg ABP; Vaz FM; Svarstad E
Clin J Am Soc Nephrol; 2017 Sep; 12(9):1470-1479. PubMed ID: 28625968
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease: a morphologic study of 11 cases.
Fischer EG; Moore MJ; Lager DJ
Mod Pathol; 2006 Oct; 19(10):1295-301. PubMed ID: 16799480
[TBL] [Abstract][Full Text] [Related]
7. Urinary Podocyte Loss Is Increased in Patients with Fabry Disease and Correlates with Clinical Severity of Fabry Nephropathy.
Fall B; Scott CR; Mauer M; Shankland S; Pippin J; Jefferson JA; Wallace E; Warnock D; Najafian B
PLoS One; 2016; 11(12):e0168346. PubMed ID: 27992580
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of Globotriaosylceramide in Podocytes in Fabry Nephropathy Is Associated with Progressive Podocyte Loss.
Najafian B; Tøndel C; Svarstad E; Gubler MC; Oliveira JP; Mauer M
J Am Soc Nephrol; 2020 Apr; 31(4):865-875. PubMed ID: 32127409
[TBL] [Abstract][Full Text] [Related]
9. Characterization of early disease status in treatment-naive male paediatric patients with Fabry disease enrolled in a randomized clinical trial.
Wijburg FA; Bénichou B; Bichet DG; Clarke LA; Dostalova G; Fainboim A; Fellgiebel A; Forcelini C; An Haack K; Hopkin RJ; Mauer M; Najafian B; Scott CR; Shankar SP; Thurberg BL; Tøndel C; Tylki-Szymańska A; Ramaswami U
PLoS One; 2015; 10(5):e0124987. PubMed ID: 25955246
[TBL] [Abstract][Full Text] [Related]
10. Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients
.
Yang N; Wang X; Xu F; Zeng C; Wang J; Liu Z
Clin Nephrol; 2017 Apr; 87 (2017)(4):188-195. PubMed ID: 28157068
[TBL] [Abstract][Full Text] [Related]
11. Fabry Disease Nephropathy: Histological Changes With Nonclassical Mutations and Genetic Variants of Unknown Significance.
Santostefano M; Cappuccilli M; Gibertoni D; Fabbrizio B; Malvi D; Demetri M; Capelli I; Tringali E; Papa V; Biagini E; Cenacchi G; Galdi A; Donadio V; Liguori R; Zoli G; La Manna G; Pasquinelli G
Am J Kidney Dis; 2023 Nov; 82(5):581-596.e0. PubMed ID: 37301502
[TBL] [Abstract][Full Text] [Related]
12. Evolution of renal pathology in Fabry disease.
Sessa A; Meroni M; Battini G; Righetti M; Nebuloni M; Tosoni A; Vago GL;
Acta Paediatr Suppl; 2003 Dec; 92(443):6-8; discussion 5. PubMed ID: 14989458
[TBL] [Abstract][Full Text] [Related]
13. Clinic-Pathologic Features and Renal Outcome of Fabry Disease: Data from a Chinese Cohort.
Zhang D; Zhang J; Liang S; Wang J; Liu Z
Am J Nephrol; 2018; 48(2):137-146. PubMed ID: 30110672
[TBL] [Abstract][Full Text] [Related]
14. Progressive podocyte injury and globotriaosylceramide (GL-3) accumulation in young patients with Fabry disease.
Najafian B; Svarstad E; Bostad L; Gubler MC; Tøndel C; Whitley C; Mauer M
Kidney Int; 2011 Mar; 79(6):663-670. PubMed ID: 21160462
[TBL] [Abstract][Full Text] [Related]
15. Bedside Stereomicroscopy of Fabry Kidney Biopsies: An Easily Available Method for Diagnosis and Assessment of Sphingolipid Deposits.
Svarstad E; Leh S; Skrunes R; Kampevold Larsen K; Eikrem Ø; Tøndel C
Nephron; 2018; 138(1):13-21. PubMed ID: 28848191
[TBL] [Abstract][Full Text] [Related]
16. Focal and segmental glomerular sclerosis (FSGS) in a man and a woman with Fabry's disease.
Svarstad E; Bostad L; Kaarbøe O; Houge G; Tøndel C; Lyngdal PT; Iversen BM
Clin Nephrol; 2005 May; 63(5):394-401. PubMed ID: 15909601
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis of Fabry nephropathy: The pathways leading to fibrosis.
Rozenfeld PA; de Los Angeles Bolla M; Quieto P; Pisani A; Feriozzi S; Neuman P; Bondar C
Mol Genet Metab; 2020 Feb; 129(2):132-141. PubMed ID: 31718986
[TBL] [Abstract][Full Text] [Related]
18. Kidney histologic alterations in α-Galactosidase-deficient mice.
Valbuena C; Oliveira JP; Carneiro F; Relvas S; Ganhão M; Sá-Miranda MC; Rodrigues LG
Virchows Arch; 2011 Apr; 458(4):477-86. PubMed ID: 21328014
[TBL] [Abstract][Full Text] [Related]
19. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical diagnosis of Fabry nephropathy and localisation of globotriaosylceramide deposits in paraffin-embedded kidney tissue sections.
Valbuena C; Leitão D; Carneiro F; Oliveira JP
Virchows Arch; 2012 Feb; 460(2):211-21. PubMed ID: 22205110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
